Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 41

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

464

HTML

3329

Figures (1-3)

211

Tables (1-2)

180

Sum=4184

Nov 7, 2012 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 7, 2012; 18(41): 5948-5956
Published online Nov 7, 2012. doi: 10.3748/wjg.v18.i41.5948

Table 1 Patient demographics and pattern of dysrhythmia according to symptom improvement

	Total patients (n = 74)		Symptom improvement (n = 52)		Symptom resistance (n = 22)
Male:female (n)	26:48		18:34		8:14
Age (range), yr	51.7 (19-70)		53.5 (27-70)		47.6 (19-70)
Height	165.2 ± 12.4		166.3 ± 11.6		164.9 ± 10.1
Weight	61.3 ± 9.7		62.3 ± 9.1		58.8 ± 10.2
	Pre-treatment	Post-treatment	Pre-treatment	Post-treatment	Pre-treatment	Post-treatment
Symptom severity score	8.09 ± 0.43	5.51 ± 0.46^a	8.90 ± 0.46	4.52 ± 0.47^a	6.18 ± 0.85	7.86 ± 0.92
Symptom frequency score	9.27 ± 0.49	6.81 ± 0.54^a	9.96 ± 0.54	5.79 ± 0.60^a	7.64 ± 1.01	9.23 ± 0.97
Gastric dysrhythmia (pre-prandial)
Bradygastria	16 (21.6)	11 (14.9)	9 (17.3)	7 (13.5)	6 (27.3)	4 (18.2)
Normogastria	33 (44.6)	52 (70.3)^a	26 (50.0)	37 (71.2)^a	9 (40.9)	15 (68.2)
Tachygastria	25 (33.8)	11 (14.9)^a	17 (32.7)	8 (15.4)^a	7 (31.8)	3 (13.6)
Gastric dysrhythmia (post-prandial)
Bradygastria	17 (23.0)	10 (13.5)	10 (19.2)	6 (11.5)	4 (18.2)	4 (18.2)
Normogastria	33 (44.6)	45 (60.8)	26 (50.0)	37 (71.2)^a	11 (50)	13 (59.1)
Tachygastria	24 (32.4)	19 (25.7)	16 (30.8)	14 (26.9)	7 (31.8)	5 (22.7)

^aP < 0.05 vs pre-treatment group. Data are presented by mean ± SD or n (%).

Table 2 Demographic and treatment success of patients and pattern of dysrhythmia according to prokinetic drugs

	Itopide (n = 24)		Mosapride (n = 28)		Levosulpiride (n = 22)
Male:female (n)	5:19		10:18		11:11
Age (range), yr	49.8 (30-64)		49.6 (19-70)		56.6 (39-70)
Height	166.1 ± 10.1		163.0 ± 11.0		167.1 ± 13.2
Weight	60.8 ± 7.7		62.7 ± 11.5		61.3 ± 10.5
Symptom improvement	18 (75)		17 (61)		17 (77)
	Pre-treatment	Post-treatment	Pre-treatment	Post-treatment	Pre-treatment	Post-treatment
Symptom severity score	7.96 ± 0.84	5.00 ± 0.86^a	7.61 ± 0.64	5.46 ± 0.79^a	8.86 ± 0.76	6.14 ± 0.76^a
Symptom frequency score	9.21 ± 0.92	6.08 ± 0.99^a	8.86 ± 0.78	6.86 ± 0.89	9.86 ± 0.83	7.55 ± 0.96
Gastric dysrhythmia (pre-prandial)
Bradygastri	5 (20.8)	4 (16.7)	6 (21.4)	4 (14.3)	4 (18.2)	3 (13.6)
Normogastria	8 (33.3)	17 (70.8)^a	15 (53.6)	18 (64.3)	12 (54.5)	15 (68.2)
Tachygastria	11 (45.8)	3 (12.6)^a	7 (25)	6 (21.4)	6 (27.3)	4 (18.2
Gastric dysrhythmia (post-prandial)
Bradygastria	5 (20.8)	3 (12.5)	6 (21.4)	6 (21.4)	3 (13.6)	1 (4.5)
Normogastria	11 (45.8)	14 (58.3)	12 (42.9)	16 (57.1)	14 (63.6)	15 (68.2)
Tachygastria	8 (33.3)	7 (29.2)	10 (35.7)	6 (21.4)	5 (22.7)	6 (27.3)

^aP < 0.05 vs pre-treatment group. Data are presented by mean ± SD or n (%).

Citation: Lim HC, Lee SI, Chen JD, Park H. Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia. World J Gastroenterol 2012; 18(41): 5948-5956
URL: https://www.wjgnet.com/1007-9327/full/v18/i41/5948.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i41.5948